Michael Egholm, Standard BioTools president and CEO (IsoPlexis)
Eli Casdin co-leads $250M infusion into microfluidics player that landed NIH funding for Covid-19 testing
In about 17 months, Fluidigm has gone from working with sharks to Vikings.
The South San Francisco-based company, which landed NIH money in a Shark …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
